Vicki D E Barone insider trades: Omni Bio Pharmaceutical (OMBP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vicki reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 6, 2013 | OMBP | ↓ Sell | 300,000 | $0.25 | $75K | By GVC Partners LLC | Mar 7, 2013 (1d) |
| Sep 7, 2012 | OMBP | ↑ Buy | 100,000 | $1.14 | $114K | By GVC Partners LLC | Jan 3, 2013 (118d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vicki D E Barone's insider trades
Vicki D E Barone is a director at Omni Bio Pharmaceutical (OMBP). Since Sep 7, 2012, Vicki has reported 1 open-market purchase worth $114K and 1 sale worth $75K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), grants and awards (4 filings), shares withheld for taxes (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OMBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.